Gastroesophageal Reflux Disease (GERD) Device Market Size, Share, Device Type (Anti-Reflux Surgery Devices, Endoscopic Devices, Drug Delivery Devices Surgery, Monitoring Devices, and Others), Application (Treatment, Diagnostics, and Monitoring), End-User

Gastroesophageal Reflux Disease (GERD) Device Market Size, Share, Device Type (Anti-Reflux Surgery Devices, Endoscopic Devices, Drug Delivery Devices Surgery, Monitoring Devices, and Others), Application (Treatment, Diagnostics, and Monitoring), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region - Trends, Analysis, and Forecast Till 2034

Gastroesophageal Reflux Disease devices are medical instruments designed to cure chronic acid reflux by attacking the very roots of this disease. These instruments strengthen the lower esophageal sphincter- a muscular ring located at the bottom of the esophagus, which guards against the backward flow of stomach contents. Surging prevalence of GERD is expected to propel market expansion during the forecast period.

Gastroesophageal Reflux Disease (GERD) Device Market Report Highlights:

The gastroesophageal reflux disease (GERD) device market size is expected to be USD 6.52 Billion by 2034.

The market was valued at USD 5.53 Billion in 2024.

The market is growing at a CAGR of 1.8% during the forecast period.

North America presently holds the largest GERD devices market share.

Asia Pacific is registering a fast growth rate in the market.

By device type, the market is dominated by the anti-reflux surgery devices segment.

On the basis of application, the treatment segment is expected to hold the largest market share during the forecast period.

The hospitals end-user segment is witnessing high growth in the market.

Gastroesophageal Reflux Disease (GERD) Device Market Key Highlights:

In August 2024, Medtronic announced the launch of its new Linx Reflux Management System, an advanced anti-reflux surgery device. The system incorporates enhanced magnetic ring technology to improve durability and patient outcomes. This launch reflects Medtronic's commitment to advancing minimally invasive GERD treatments and addressing unmet needs in chronic reflux management.

In July 2024, Boston Scientific introduced an upgraded version of its Endoscopic Suture System, which enhances the precision and efficiency of endoscopic anti-reflux procedures. The new system features a streamlined delivery mechanism and improved suture materials to reduce procedure times and enhance patient comfort.

Key Benefits of Purchasing This Report

Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.

Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.

Stay informed on the latest trends in the Gastroesophageal Reflux Disease (GERD) Device Market, including key drivers, challenges, opportunities, and barriers.

Gastroesophageal Reflux Disease (GERD) Device Market Report Analysis:

GERD can Usually Be Controlled with Medicine. But If Medicines Don't Help or Patient Wish to Avoid Long-Term Medicine Use, a Healthcare Professional Might Recommend–

Fundoplication- The surgeon wraps the top of the stomach around the lower esophageal sphincter, to tighten the muscle and prevent reflux. Fundoplication is usually done with a minimally invasive, called laparoscopic, procedure. The wrapping of the top part of the stomach can be partial or complete, known as Nissen fundoplication. The most common partial procedure is the Toupet fundoplication. Your surgeon typically recommends the type that is best for you.

LINX device- A ring of tiny magnetic beads is wrapped around the junction of the stomach and esophagus. The magnetic attraction between the beads is strong enough to keep the junction closed to refluxing acid, but weak enough to allow food to pass through. The LINX device can be implanted using minimally invasive surgery. The magnetic beads do not affect airport security or magnetic resonance imaging.

Transoral incisionless fundoplication (TIF) - This new procedure involves tightening the lower esophageal sphincter by creating a partial wrap around the lower esophagus using polypropylene fasteners. TIF is performed through the mouth by using an endoscope and requires no surgical incision. Its advantages include quick recovery time and high tolerance.

Segmentation:

By Device Type:

Anti-Reflux Surgery Devices

Endoscopic Devices

Drug Delivery Devices Surgery

Monitoring Devices

Others

By Application:

Treatment

Diagnostics

Monitoring

By End-User:

Hospitals

Ambulatory Surgery Centers

Others

By Region:

North America

U.S.

Canada

Europe

Germany

U.K.

France

Russia

Italy

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC

Israel

South Africa

Rest of Middle East & Africa

Gastroesophageal Reflux Disease (GERD) Device Market Competitive Landscape:

Medtronic PLC

Johnson & Johnson Services, Inc.

Boston Scientific Corporation

EndoStim, Inc.

Olympus Corporation

Laborie Medical Technologies

Medigus Ltd.

Mederi Therapeutics Inc.

Ethicon, Inc. (A subsidiary of Johnson & Johnson)

Torax Medical, Inc. (Acquired by Medtronic)

Koninklijke Philips N.V.

Cook Medical Inc.

Diversatek Healthcare Inc.

C2 Therapeutics

FUJIFILM Holdings Corporation

Key Questions Answered in This Report

1. What was the size of the Gastroesophageal Reflux Disease (GERD) Device Market in 2024?

2. What is the expected growth rate of the Gastroesophageal Reflux Disease (GERD) Device Market during 2025-2035?

3. What are the key factors driving the Gastroesophageal Reflux Disease (GERD) Device Market?

4. What is the breakup of the Gastroesophageal Reflux Disease (GERD) Device Market based on the distribution channel?

5. What are the key regions in the Gastroesophageal Reflux Disease (GERD) Device Market?

6. Who are the key players/companies in the Gastroesophageal Reflux Disease (GERD) Device Market?

7. What are the drivers, restraints, and opportunities in the Gastroesophageal Reflux Disease (GERD) Device Market?